Molgramostim Inhalation Solution

Name: Molgramostim Inhalation Solution in Autoimmune pulmonary alveolar proteinosis: Clinical presentation - signs and symptoms
Published: 2026-09-14T15:39:06-04:00

Autoimmune pulmonary alveolar proteinosis

Manufacturer: Savara
Regulatory submission: BLA resubmitted December 2025
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Clinical presentation - signs and symptoms

2 evidence topics · 1 source

Respiratory symptoms: dyspnea, cough, and sputum production

“Common symptoms of autoimmune PAP” (opens the source at this quote in a new tab)
“Shortness of breath” (opens the source at this quote in a new tab)
“Cough” (opens the source at this quote in a new tab)
“Sputum production” (opens the source at this quote in a new tab)

Functional symptoms: fatigue and reduced exercise capacity

“Fatigue” (opens the source at this quote in a new tab)
“Reduced exercise capacity” (opens the source at this quote in a new tab)